title: PCSK9 Inhibition to Lower LDL-Cholesterol and Reduce Cardiovascular Risk: Great Expectations.
authors.affiliation: From the Division of Cardiology, San Francisco General Hospital, and the Department of Medicine, University of California, San Francisco. David.Waters@ucsf.edu.
authors.forename: David D
authors.initials: DD
authors.lastname: Waters
authors.affiliation: From the Division of Cardiology, San Francisco General Hospital, and the Department of Medicine, University of California, San Francisco.
authors.forename: Priscilla Y
authors.initials: PY
authors.lastname: Hsue